CEA Plasmid as Therapeutic DNA Vaccination against Colorectal Cancer
<strong>Background:</strong> Human colorectal cancer cells overexpress carcinoembryonic antigen (CEA). CEA is a glycoprotein which has shown to be a promising vaccine target for immunotherapy against colorectal cancer. <strong>Objective:</strong> To design a DNA vaccine harbo...
Main Authors: | Ziba Veisi Malekshahi, Nasser Hashemi Goradel, Mehdi Shakouri Khomartash, Amir Maleksabet, Maryam kadkhodazadeh, Gholam Ali Kardar, Babak Negahdari |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2019-09-01
|
Series: | Iranian Journal of Immunology |
Subjects: | |
Online Access: | http://iji.sums.ac.ir/article_45570_11b9b1486370a903ce3d0350840ca060.pdf |
Similar Items
-
Multivariate Analysis of Prognostic Determinants for Colorectal Cancer Patients with High Preoperative Serum CEA Levels: Prognostic Value of Postoperative Serum CEA Levels
by: Cheng-Jen Ma, et al.
Published: (2006-12-01) -
The role of serum IL-6 in colorectal cancer patients and it’s relationship with serum CEA level
by: Batool H. Al-Ghurabi, et al.
Published: (2010-01-01) -
Evaluation of the Relationship between Peroxisome Proliferator Receptors (PPARα, PPARγ, and PPARδ) Expression and Carcinoembryonic Antigen (CEA) in Patients with Colorectal Cancer
by: Musa Yaghoubizadeh, et al.
Published: (2022-08-01) -
Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns
by: Qianqian Zhao, et al.
Published: (2018-03-01) -
Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer
by: Thomas A. Odeny, et al.
Published: (2020-11-01)